about
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsAwareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer ScreeningAssociation between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerPolymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskOvarian cancer screening--current status, future directionsContribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMixed methods evaluation of well-being benefits derived from a heritage-in-health intervention with hospital patientsA genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Causal Associations of Adiposity and Body Fat Distribution with Coronary Heart Disease, Stroke Subtypes and Type 2 Diabetes: A Mendelian Randomization Analysis.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAssessing the genetic architecture of epithelial ovarian cancer histological subtypes.Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Socioeconomic indicators of health inequalities and female mortality: a nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.Progress and challenges in screening for early detection of ovarian cancer.Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.Serum peptide profiling using MALDI mass spectrometry: avoiding the pitfalls of coated magnetic beads using well-established ZipTip technology.Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle studyAn epigenetic signature in peripheral blood predicts active ovarian cancerHormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyA well-characterised peak identification list of MALDI MS profile peaks for human blood serum.Identifying hopelessness in population research: a validation study of two brief measures of hopelessness.Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer ScreeningA genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Development of a multimarker assay for early detection of ovarian cancer.
P50
Q21144976-1AEAB6F9-C4E0-48B4-B105-17E9BF5C5659Q21203736-ED5CCECF-6EF8-4039-A81E-9CC9865537D6Q24608602-C373B477-5385-48E8-BAE7-161C33D576C9Q24619808-C0B55339-4BF1-4EAB-B867-395C560F2BC0Q24633316-B6792473-7B80-4652-9FD6-6BD80E88B0FEQ24648412-FB8EC19E-CCDA-427C-BA4F-5C0FAA45D2D3Q26780387-3A7ACFFB-8116-49C2-B835-04A8E9124987Q26799669-060BCB5D-5ADF-4D20-9225-2B3EEB001ADFQ27004471-ECF25C2F-BB65-474A-BEA3-5B81228C2DDAQ28266112-B31B2548-781B-4CDC-BFE9-AD5E33EDFC1EQ28388497-C18C41CE-348E-4951-BFEA-683141070043Q28584533-CB8AB049-9202-4388-AB08-9AEEEDC83AFDQ28652615-D4C9C267-A093-446D-9131-9A2124A5B298Q29417084-83CD4379-4F37-4D80-B96B-9EFC07A179F8Q30252417-771285F4-CCAD-4A83-BFC5-FC34DFBE9807Q30252854-DE44BB49-2E2D-44E6-924F-C13F9D9CC6A7Q30275068-00F01A9B-A804-4BC3-AF07-4677A74B9469Q30275832-59FB22A5-DACB-4CBC-AF2B-1C35DEB6A802Q30276359-F5BC409F-EDD3-4347-85F5-2058FEF5586FQ30276986-010A5F1D-12A5-446C-A5C3-08E1781EDAC6Q30277016-C104FA34-6034-4C53-BF89-033966B7056DQ30277151-D0A6F5ED-2BFB-42B0-9A8D-E1E7FC13BB1FQ30277784-9788DC44-1689-489D-8D56-04F72CCB74A3Q30374367-EC047E18-201D-4F07-A690-881F3CC04A35Q30630536-6E67EA3B-85ED-4A1C-BCAC-429C50CFA58BQ30724410-05B4494C-F669-4266-A131-5C8AA321E22AQ31012361-CD8B2727-3E08-4B91-9E87-C29E7655B904Q31041170-A9A44706-2734-480D-92F5-E10E13DC357FQ33274039-6C0BA76C-2143-4B5C-ADFC-27F7DE9F74D6Q33300244-40E81A7D-6633-43A7-9ECD-24FE3DC9B5AEQ33352027-5FC59FB5-A0D4-44F8-A4F6-6DA2F71982A1Q33519528-3404FEAA-AD18-4CD5-AEAA-2C115A0A6291Q33551425-C14BAAAD-96E2-418E-A3DD-1CF5451DF3BCQ33656838-C4D906BE-40B1-4AFB-B823-7C9D0495F9C7Q33691481-0A837852-0458-4F01-938E-15F533235DC2Q33738275-2BEDEBD4-EE5D-4B44-87B3-8D8263DEC8D7Q33747778-A3EAAA22-7FF7-45EB-9F6B-C145D5443FEBQ33762434-5AEC7180-2BDE-4626-B1C1-211F7572C65FQ33778612-1586B5C0-B663-45CE-8E5D-D84B427CE218Q33813724-06C37355-35F2-42F2-9C6B-16B3D13212E3
P50
description
onderzoeker
@nl
researcher, professor of gynaecological cancer
@en
name
Usha Menon
@ast
Usha Menon
@en
Usha Menon
@es
Usha Menon
@nl
Usha Menon
@sl
type
label
Usha Menon
@ast
Usha Menon
@en
Usha Menon
@es
Usha Menon
@nl
Usha Menon
@sl
prefLabel
Usha Menon
@ast
Usha Menon
@en
Usha Menon
@es
Usha Menon
@nl
Usha Menon
@sl
P21
P31
P496
0000-0003-3708-1732